Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Two events Nov 7

<< Previous

Bullboard Posts

Next >>

Comment by Lesalpes29on Oct 28, 2022 5:52am

181 Views

Post# 35055135

RE:RE:Two events Nov 7

Timing is everything And it seems management planned those two events very close in Time on purpose. Very confident to see things unfold on the positive side. Otherwise I will have to ask myself ‘what I don’t understand or what the f... is going in management head’!? Have a great weekend,

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec